Embecta Corp. (EMBC)

Revenue by Segment

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019
Disposable Medical Products	1.08B	1.12B	1.12B	1.13B	1.17B
Disposable Medical Products Growth	-3.80%	0.21%	-0.77%	-3.07%	7.35%
Total	1.08B	1.12B	1.12B	1.13B	1.17B
Total Growth	-3.80%	0.21%	-0.77%	-3.07%	7.35%

Revenue by Geography

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019
United States	579.10M	607.20M	601.40M	600.30M	609.40M
United States Growth	-4.63%	0.96%	0.18%	-1.49%	8.24%
International	501.30M	515.90M	519.40M	529.20M	555.90M
International Growth	-2.83%	-0.67%	-1.85%	-4.80%	6.39%
Total	1.08B	1.12B	1.12B	1.13B	1.17B
Total Growth	-3.80%	0.21%	-0.77%	-3.07%	7.35%

Data Source: S&P Global Market Intelligence Last updated: May 5, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 29, 2026

Data Sources Report a data error